Abiopharma

🔍 Ahlborn Andrew (Executive)

Company: Ready Capital Corp (RC)

Report Date: 2025-12-24

Detailed Transactions and Holdings:

• Sold 25,248 shares of Common Stock at $2.23 per share (Direct)
  Date: 2025-12-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,176,822.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 27,950 shares of Common Stock at $1.74 per share (Direct)
  Date: 2026-03-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 1,148,872.00 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: Consists of shares of Common Stock withheld by the Issuer, with approval of the Issuer's Board of Directors, in order to satisfy the tax withholding obligation of the reporting person in connection with the vesting of shares of Common Stock granted on February 3, 2025.
• F2: Represents the closing price of the Common Stock on December 23, 2025.
• F3: Consists of shares of Common Stock withheld by the Issuer, with approval of the Issuer's Board of Directors, in order to satisfy the tax withholding obligation of the reporting person in connection with the vesting of shares of Common Stock granted on February 22, 2025, February 22, 2024 and February 12, 2023.
• F4: Represents the closing price of the Common Stock on March 13, 2026.
• REMARKS: Exhibit No. 24.1 Power of Attorney dated March 17, 2026.